CD4 and myeloid sarcoma: The predominant preclinical model of MS is experimental autoimmune encephalomyelitis (EAE), in which laboratory animals are immunized with myelin proteins or peptides to activate antigen-specific CD4+ T cells that infiltrate the CNS and mediate disease.